Analysts See 70% Upside Potential in Corcept Therapeutics (CORT) Stock
As of the close of December 2, the consensus shows that analyst opinions are highly favourable towards Corcept Therapeutics Incorporated (NASDAQ:CORT), with 80% of analysts covering it assigning a Buy...






